Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Annual Report · 10-K

Standard BioTools Inc.

LABNASDAQEQUITYCurrent

Annual Report

Filed Mar 1, 2024Accepted Mar 1, 2024, 4:09 PM ESTCIK 1162194Accession 0000950170-24-023845
Share

Company context

Standard BioTools, Inc. (NASDAQ: LAB), is committed to setting the new standard in the life science tools industry through strategic consolidation, best-in-class operations and a world-class management team. The Company's established portfolio includes essential, standardized next-generation solutions designed to help biomedical researchers develop better therapeutics faster. For Research Use Only. Not for use in diagnostic procedures.

Current securities

Historical securities (1)

Recent company filings

  1. S-4/A filingSep 9, 2026
  2. 4 filingAug 24, 2026
  3. SCHEDULE 13G/A filingAug 14, 2026
  4. SCHEDULE 13G filingAug 14, 2026
  5. S-8 filingAug 5, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗